1. High expression of ladinin-1 (LAD1) predicts adverse outcomes: a new candidate docetaxel resistance gene for prostatic cancer (PCa)
   Jianping Li et al, 2021, Bioengineered CrossRef
2. Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
   Theo Battista et al, 2020, Cancers CrossRef
3. The prognostic significance and potential mechanism of DBF4 zinc finger in hepatocellular carcinoma
   Zhongkai Wu et al, 2024, Scientific Reports CrossRef
4. Expression profile-based screening for critical genes reveals S100A4, ACKR3 and CDH1 in docetaxel-resistant prostate cancer cells
   Sha Zhu et al, 2019, Aging CrossRef
5. Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins
   Ilaria Genovese et al, 2017, Drug Resistance Updates CrossRef
6. Activation of the ABCB1 Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer Cells
   Alan P. Lombard et al, 2021, Molecular Cancer Therapeutics CrossRef
7. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
   Luciana Mosca et al, 2021, Drug Resistance Updates CrossRef
8. Insights into molecular mechanisms of chemotherapy resistance in cancer
   Animesh Kar et al, 2024, Translational Oncology CrossRef
9. Sorcin in Cancer Development and Chemotherapeutic Drug Resistance
   Cécile Exertier et al, 2024, Cancers CrossRef